Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3374-3378

  Gorski, David H ^a   Beckett, Michael A ^a   Jaskowiak, Nora T ^a   Calvin, Douglas P ^a   Mauceri, Helena J ^a   Salloum, Rabih M ^a   Seetharam, Saraswathy ^a   Koons, Ann ^a   Hari, Danielle M ^a   Kufe, Donald W ^b   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; MESSENGER RNA; MONOCLONAL ANTIBODY; RADIOSENSITIZING AGENT; RNA; TUMOR PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; ESOPHAGUS CARCINOMA; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; LEWIS CARCINOMA; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR VOLUME; ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ESOPHAGUS TUMOR; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; STRESS; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MELANOMA; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RNA, MESSENGER; RNA, NEOPLASM; STRESS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033564974     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
2. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
3. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
4. Thomas, K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem., 271: 603-606, 1996.
5. Asano, M., Yukita, A., Matsumoto, T., Kondo, S., and Suzuki, H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor-121. Cancer Res., 55: 5296-5301, 1995.
6. Borgstrom, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56: 4032-4039, 1996.
7. Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., Thomas, K. A., and Curiel, D. T. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. USA, 95: 8795-8800, 1998.
8. Kanai, T., Konno, H., Tanaka, T., Baba, M., Matsumoto, K., Nakamura, S., Yukita, A., Asano, M., Suzuki, H., and Baba, S. Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. Int. J. Cancer, 77: 933-936, 1998.
9. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth-factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
10. Grunstein, J., Roberts, W. G., Mathieu-Costello, O., Hanahan, D., and Johnson, R. S. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res., 59: 1592-1598, 1999.
11. Gridley, D. S., Loredo, L. N., Slater, J. D., Archambeau, J. O., Bedros, A. A., Andres, M. L., and Slater, J. M. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect. Prev., 22: 20-29, 1998.
12. Gorski, D. H., Mauceri, H. J., Salloum, R. M., Gately, S., Hellman, S., Beckett, M. A., Sukhatme, V. P., Soff, G. A., Kufe, D. W., and Weichselbaum, R. R. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res., 58: 5686-5689, 1998.
13. Mauceri, H., Hanna, N., Beckett, M., Gorski, D. H., Staba, M. J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G., Sukhatme, V. P., Kufe, D., and Weichselbaum, R. R. Interaction of angiostatin and ionizing radiation in anti-tumour therapy. Nature (Lond.), 394: 287-291, 1998.
14. Hughes, S. J., Nambu, Y., Soldes, O. S., Hamstra, D., Rehemtulla, A., Iannettoni, M. D., Orringer, M. B., and Beer, D. G. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma. Cancer Res., 57: 5571-5578, 1997.
15. Weichselbaum, R. R., Dahlberg, W., and Little, J. B. Inherently radioresistant cells exist in some human tumors. Proc. Natl. Acad. Sci. USA, 82: 4732-4735, 1985.
16. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
17. Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Ananth, S., and Sukhatme, V. P. The von Hippel-Lindau tumor suppressor gene product interacts with SpI to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol., 17: 5629-5639, 1997.
18. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
19. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res., 47: 943-946, 1987.